ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,651 | -24.8% | 135,883 | -0.2% | 0.01% | -18.2% |
| Q2 2023 | $4,856 | +39.5% | 136,183 | -0.7% | 0.01% | +37.5% |
| Q1 2023 | $3,482 | -37.3% | 137,083 | +0.1% | 0.01% | -42.9% |
| Q4 2022 | $5,556 | -99.9% | 136,983 | 0.0% | 0.01% | +16.7% |
| Q3 2022 | $4,527,000 | -5.9% | 136,983 | +0.2% | 0.01% | 0.0% |
| Q2 2022 | $4,813,000 | -23.2% | 136,683 | +0.4% | 0.01% | -7.7% |
| Q1 2022 | $6,263,000 | -30.5% | 136,183 | +0.1% | 0.01% | -23.5% |
| Q4 2021 | $9,016,000 | +16.6% | 135,983 | +9.8% | 0.02% | +6.2% |
| Q3 2021 | $7,733,000 | -21.8% | 123,864 | +3.8% | 0.02% | -23.8% |
| Q2 2021 | $9,886,000 | +15.6% | 119,372 | -7.4% | 0.02% | +16.7% |
| Q1 2021 | $8,552,000 | -19.2% | 128,972 | -6.5% | 0.02% | -21.7% |
| Q4 2020 | $10,587,000 | +74.4% | 137,972 | -2.1% | 0.02% | +53.3% |
| Q3 2020 | $6,070,000 | -0.9% | 140,972 | -0.6% | 0.02% | 0.0% |
| Q2 2020 | $6,123,000 | +70.2% | 141,772 | +13.4% | 0.02% | +36.4% |
| Q1 2020 | $3,598,000 | -53.0% | 125,072 | +3.6% | 0.01% | -38.9% |
| Q4 2019 | $7,661,000 | +98.2% | 120,772 | -12.0% | 0.02% | +80.0% |
| Q3 2019 | $3,865,000 | +257.9% | 137,166 | +236.5% | 0.01% | +233.3% |
| Q2 2019 | $1,080,000 | – | 40,766 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |